ISSN 2472-0429

Advances in Cancer Prevention
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • Adv Cancer Prev,

Extensive Preclinical Mechanistic Evaluation of Cancer Therapy Agents

Qiang Nai*
Department of Anatomy and Neurobiology, University of Tennessee, U.S.A
*Corresponding Author : Qiang Nai, Department of Anatomy and Neurobiology, University of Tennessee, U.S.A, Email: qiangnai@yahoo.com

Received Date: Feb 28, 2023 / Published Date: Mar 28, 2023

Abstract

Since it has been shown that the cellular signalling network, e.g. regulation of apoptosis is influenced by 3D cell organization and multicellular complexity, new cell culture models for a more realistic investigation of tumour cell behaviour ex vivo are urgently needed.

Citation: Nai Q (2023) Extensive Preclinical Mechanistic Evaluation of CancerTherapy Agents. Adv Cancer Prev 7: 159.

Copyright: © 2023 Nai Q. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Post Your Comment Citation
Share This Article
Article Usage
  • Total views: 396
  • [From(publication date): 0-2023 - Sep 18, 2024]
  • Breakdown by view type
  • HTML page views: 345
  • PDF downloads: 51
Top